Status:

UNKNOWN

Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes

Lead Sponsor:

National University Hospital, Singapore

Collaborating Sponsors:

Jana Care

Conditions:

Gestational Diabetes

Pregnancy Complications

Eligibility:

FEMALE

21+ years

Phase:

NA

Brief Summary

Gestational diabetes mellitus (GDM) affects one fifth of Singaporean pregnancies and can result in short and long term complications for mother and child. Mobile applications are effective in improvin...

Detailed Description

Gestational diabetes mellitus (GDM) is defined as glucose intolerance of any degree with onset or first recognition during pregnancy. In Singapore, 20-30% of pregnant women are affected by GDM. If poo...

Eligibility Criteria

Inclusion

  • Ability to provide informed consent.
  • Women aged 21 years and older.
  • Singleton pregnancy.
  • GDM diagnosed between 12 to 30 weeks of gestation, based on the 2013 World Health Organization (WHO) criteria, i.e. either of the following: fasting plasma glucose ≥5.1 mmol/L, 60-minute plasma glucose ≥10.0 mmol/L, 120-minute plasma glucose ≥8.5 mmol/L, during a 75g oral glucose tolerance test (OGTT).
  • Possesses a smartphone and ability to navigate a smartphone app.
  • Proficient in English language.
  • Plan to deliver the baby in National University Hospital.

Exclusion

  • Multiple pregnancy.
  • Pre-existing diabetes (type 1 diabetes, type 2 diabetes, or other specific types of diabetes) diagnosed prior to current pregnancy.
  • GDM diagnosed before 12 weeks of gestation.
  • No weight available in first trimester (at or before 12 weeks gestation) of the pregnancy.
  • Need for insulin therapy from the start of diagnosis of GDM, as determined by the primary clinician.
  • Heart failure.
  • Chronic kidney disease
  • Feeding and eating disorders.
  • History of bariatric surgery.
  • Long-term systemic corticosteroids use.
  • Impaired mobility.
  • Concomitant participation in another clinical study (i.e. Phase I-III clinical studies) with investigational medicinal product(s).

Key Trial Info

Start Date :

September 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2019

Estimated Enrollment :

340 Patients enrolled

Trial Details

Trial ID

NCT03249896

Start Date

September 5 2017

End Date

May 1 2019

Last Update

May 29 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National University Hospital

Singapore, Singapore, 119228